During the past decade, Tampa Bay Nephrology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tampa Bay Nephrology Associates" are "Hypertension" (3 trials), "Diabetes Mellitus, Type 2" (2 trials), "Hyperphosphatemia" (1 trials), "Renal Insufficiency" (1 trials) and "Renal Insufficiency, Chronic" (1 trials). Many other conditions were trialed in "Tampa Bay Nephrology Associates" in a lesser frequency.

Most popular intervention types in "Tampa Bay Nephrology Associates" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (3 trials), "Guanfacine" (2 trials), "vildagliptin" (2 trials), "Darusentan Placebo" (1 trials) and "Sitagliptin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tampa Bay Nephrology Associates" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Tampa Bay Nephrology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Tampa Bay Nephrology Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tampa Bay Nephrology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".